Drugs used in Diabetes

Composition:
Each 1 ml contains: ‎
Recombinant human insulin 12 or 30 IU
‎Recombinant human Protamine-insulin 28 or 70 IU

Indications:
‎Diabetes mellitus type I: (insulin dependant) in children and adults.
‎Diabetes mellitus type II :( non insulin dependant) at...

Enavogliflozin is a best-in-class SGLT2 inhibitor for T2DM.


Highlights of Enavogliflozin:
* NDA filed, Accelerated Approval granted by MFDS, expected market approval within 2022 for T2DM
* T2DM Phase III was completed in Korea as a stand-alone and as combinations with other anti...

In case of subcutaneous injection, the drug begins to act within 30 minutes, reaches its maximum effect within the period from 1-3 hours after injection. Duration of action is 8 hours.
Profile of the drug action depends on dosage and reflects significant individual features.

Indications: qq...

Insulin H NPH 100 IU Injection

Recombinant Human Insulin (cartriges)

[ARB+SGLT-2i Fixed Dose Combination] – In process of Phase 3 clinical trial on approx. 250 patients
1. The first Fixed Dose Combination treating hypertension and type 2 diabetes by a tablet in the world

2. Expect the synergistic effect in the treatment of hypertension though mi...